255 related articles for article (PubMed ID: 23312054)
1. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia.
Hu M; Mak VW; Tomlinson B
J Clin Lipidol; 2012; 6(6):585-92. PubMed ID: 23312054
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia.
Zhang L; He S; Li Z; Gan X; Li S; Cheng X; Yang N; Zheng F
Lipids Health Dis; 2019 Jun; 18(1):129. PubMed ID: 31153375
[TBL] [Abstract][Full Text] [Related]
3. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.
Hu M; Lui SS; Mak VW; Chu TT; Lee VW; Poon EW; Tsui TK; Ko GT; Baum L; Tam LS; Li EK; Tomlinson B
Pharmacogenet Genomics; 2010 Oct; 20(10):634-7. PubMed ID: 20679960
[TBL] [Abstract][Full Text] [Related]
5. Variable frequencies of apolipoprotein E genotypes and its effect on serum lipids in the Guangxi Zhuang and Han children.
Hu P; Qin YH; Lei FY; Pei J; Hu B; Lu L
Int J Mol Sci; 2011; 12(9):5604-15. PubMed ID: 22016612
[TBL] [Abstract][Full Text] [Related]
6. Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia.
Carmena-Ramón R; Real JT; Ascaso JF; Ordovás JM; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):7-13. PubMed ID: 10812582
[TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.
Brito DD; Fernandes AP; Gomes KB; Coelho FF; Cruz NG; Sabino AP; Cardoso JE; Figueiredo-Filho PP; Diamante R; Norton CR; Sousa MO
Mol Biol Rep; 2011 Oct; 38(7):4381-8. PubMed ID: 21132386
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels.
Hubacek JA; Lánská V; Skodová Z; Adámková V; Poledne R
Eur J Hum Genet; 2008 Jan; 16(1):135-8. PubMed ID: 17957227
[TBL] [Abstract][Full Text] [Related]
10. [Influence of apolipoprotein E gene polymorphism on the lipid regulation by xuezhikang capsule].
Jiang WM; Lai RS; Chen XH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Aug; 29(8):688-91. PubMed ID: 19848197
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study).
Guardiola M; Ribalta J; Gómez-Coronado D; Lasunción MA; de Oya M; Garcés C
Atherosclerosis; 2010 Oct; 212(2):543-7. PubMed ID: 20688329
[TBL] [Abstract][Full Text] [Related]
14. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.
Liu ZK; Hu M; Baum L; Thomas GN; Tomlinson B
Atherosclerosis; 2010 Feb; 208(2):427-32. PubMed ID: 19732897
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
[TBL] [Abstract][Full Text] [Related]
16. CYP2C9 Genetic Polymorphism is a Potential Predictive Marker for the Efficacy of Rosuvastatin Therapy.
Lin J; Zhang Y; Zhou H; Wang X; Wang W
Clin Lab; 2015; 61(9):1317-24. PubMed ID: 26554252
[TBL] [Abstract][Full Text] [Related]
17. APOE, CETP and LPL genes show strong association with lipid levels in Greek children.
Smart MC; Dedoussis G; Louizou E; Yannakoulia M; Drenos F; Papoutsakis C; Maniatis N; Humphries SE; Talmud PJ
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):26-33. PubMed ID: 19403283
[TBL] [Abstract][Full Text] [Related]
18. Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women.
Lee KH; Kim OY; Lim HH; Lee YJ; Jang Y; Lee JH
Metabolism; 2010 Nov; 59(11):1583-90. PubMed ID: 20303129
[TBL] [Abstract][Full Text] [Related]
19. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
[TBL] [Abstract][Full Text] [Related]
20. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
